NewsShow news

First clinical study findings published in Anesthesiology

1st of January 2017
Anesthesiology, the prestigious journal of the American Society of Anesthesiologists, has published our first findings in an article titled .
The study conducted in collaboration with the Oulu University Hospital tested the possibility of using propofol-induced slow-wave activity as an early predictor of neurologic outcome after cardiac arrest. As the editors of the journal point out, no reliable methods currently exist for assessing brain function in the early stages of recovery from hypoxic, ischemic, or traumatic insults that might inform neurologic prognosis and therapy.
In the study of comatose cardiac arrest survivors, propofol-induced slow-wave activity was present in a greater proportion of patients with good neurologic outcome than in those with poor outcome. The promising finding of the study is expected to lead to the development of a pharmacologic test for the prognostication of brain injury.

Would you like to know more?

We would be happy to tell you more about our technology, and talk about possible avenues of collaboration. So please don't hesitate to contact us for more information.

Contact us

Dr. Timo Koskela, CEO
tel. +358 40 5773 706
e-mail

Visit us

Cerenion Oy
Paavo Havaksen tie 5C
90570 Oulu
FINLAND
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Under no circumstances shall the information on this website be construed as an advertisement of any commercially available product. Cerenion™, Cerenion C-Trend™, C-Trend™ and ''The pulse of the brain''™ are trademarks of Cerenion Oy. Cerenion technology is covered by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2017.